Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

GSK3-IN-1

GSK3-IN-1 (compound 11) is a GSK-3 inhibitor with an IC50 value of 12 μM. GSK3-IN-1 can be used in the research of diabetes[1].

Product Specifications

CAS Number

478482-74-5

UNSPSC

12352005

Hazard Statement

H315-H319-H320

Target

GSK-3

Type

Reference compound

Related Pathways

PI3K/Akt/mTOR; Stem Cell/Wnt

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/gsk3-in-1.html

Purity

99.86

Solubility

DMSO : 100 mg/mL (ultrasonic; warming; heat to 52°C)

Smiles

ClC1=C(CSC2=NN=C(C3=CC=NC=C3)O2)C=CC=C1

Molecular Formula

C14H10ClN3OS

Molecular Weight

303.77

Precautions

P264-P280-P302+P352-P305+P351+P338-P362

References & Citations

[1]Lars Naerum, et al. Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. Bioorg Med Chem Lett. 2002 Jun 3;12 (11) :1525-8.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Dedicated for Diverse Library

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Succinimidyl Nervonate
TRC-S690950-25MG 25 mg

Succinimidyl Nervonate

Sign In for Pricing
View Details
4-Dodecylbenzenesulfonic Acid Potassium Salt
TRC-D494560-1G 1 g

4-Dodecylbenzenesulfonic Acid Potassium Salt

Sign In for Pricing
View Details
Mouse 2810405F15Rik activation kit by CRISPRa
GA208383 1 Kit

Mouse 2810405F15Rik activation kit by CRISPRa

Sign In for Pricing
View Details
Optitrol NAT CMV
NT02021 5x 1.2 mL

Optitrol NAT CMV

Sign In for Pricing
View Details
Tissue FFPE Sections, Prostate
CS707585 5x 5 µm

Tissue FFPE Sections, Prostate

Sign In for Pricing
View Details
Tissue FFPE Sections, Liver
CS709535 5x 5 µm

Tissue FFPE Sections, Liver

Sign In for Pricing
View Details